S&P revises Boston Scientific outlook to negative on franchise pressures
Summary
Credit rating agency S&P has changed its financial outlook for Boston Scientific from stable to negative. This adjustment reflects growing business pressures facing the medical technology company across its major product franchises.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.